Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Firas Hamdan

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Molecular Therapy. Oncology|June 30, 2026
Patient-derived tumor organoids for personalized cancer immunotherapy: An immunopeptidome-to-validation approach in RCC and BCGabriella Antignani, Michaela Feodoroff, Jacopo Chiaro, et al.
ACS Nano|October 4, 2021
PeptiCHIP: A Microfluidic Platform for Tumor Antigen Landscape IdentificationSara Feola, Markus Haapala, Karita Peltonen, et al.
Frontiers in Immunology|February 23, 2023
Development of a Syrian hamster anti-PD-L1 monoclonal antibody enables oncolytic adenoviral immunotherapy modelling in an immunocompetent virus replication permissive settingJames H A Clubb, Tatiana V Kudling, Mykhailo Girych, et al.
Iscience|January 9, 2026
Novel adenovirus vaccine vectors lacking thrombosis-associated interactions with platelet factor 4Erwan Sallard, Daniel Pembaur, Matias Ciancaglini, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Molecular Therapy. Oncology|June 30, 2026
Patient-derived tumor organoids for personalized cancer immunotherapy: An immunopeptidome-to-validation approach in RCC and BCGabriella Antignani, Michaela Feodoroff, Jacopo Chiaro, et al.
ACS Nano|October 4, 2021
PeptiCHIP: A Microfluidic Platform for Tumor Antigen Landscape IdentificationSara Feola, Markus Haapala, Karita Peltonen, et al.
Frontiers in Immunology|February 23, 2023
Development of a Syrian hamster anti-PD-L1 monoclonal antibody enables oncolytic adenoviral immunotherapy modelling in an immunocompetent virus replication permissive settingJames H A Clubb, Tatiana V Kudling, Mykhailo Girych, et al.
Iscience|January 9, 2026
Novel adenovirus vaccine vectors lacking thrombosis-associated interactions with platelet factor 4Erwan Sallard, Daniel Pembaur, Matias Ciancaglini, et al.
Pageof 4